1. Abeywardena MY, Patten GS (2011) Role of ω3 Longchain polyunsaturated fatty acids in reducing cardio-metabolic risk factors. Endocr Metab Immune Disord Drug Targets 11:232–246
2. Alvarez-Nolting R, Arnal E, Barcia JM, Miranda M, Romero FJ (2012) Protection by DHA of early hippocampal changes in diabetes: possible role of CREB and NF-κB. Neurochem Res 37:105–115
3. Amtul Z, Uhrig M, Rozmahel RF, Beyreuther K (2011a) Structural insight into the differential effects of omega-3 and omega-6 fatty acids on the production of Abeta peptides and amyloid plaques. J Biol Chem 286:6100–7107
4. Amtul Z, Westaway D, Cechetto DF, Rozmahel RF (2011b) Oleic acid ameliorates amyloidosis in cellular and mouse models of Alzheimer’s disease. Brain Pathol 21:321–329
5. Arai T, Wakabayashi S, Channing MA, Dunn BB, Der MG, Bell JM, Herscovitch P, Eckelman WC, Rapoport SI, Chang MC (1995) Incorporation of [1-carbon-11]palmitate in monkey brain using PET. J Nucl Med 36:2261–2267